Navigation Links
Stanford/Packard scientist's data-mining technique strikes genetic gold

o their particular research topic, most scientific journals require that their authors submit all of their data to international databases for use by other researchers.

Butte and his Harvard co-author, Isaac Kohane, MD, PhD, used computer programs to automatically categorize the tens of thousands of microarray experiments in a single database based on the terms, or concepts, used by the submitter to describe the experiment. They then looked for findings shared by several experiments with similar concepts, such as tissue type, for example. Comparing results from many similar experiments allowed them to identify correlations that may not be statistically significant in just one experiment.

Butte and Kohane identified several previously unknown correlations: nine genes whose expression increased or decreased significantly with aging, two genes that are highly expressed in response to injury, and another gene in which the expression drops significantly in leukemic cells. They also confirmed these relationships by studying genes known to be associated with muscle tissue in both humans and mice.

Their classification system was stymied, however, when scientists included too much or too little information in the text annotations, or used imprecise words such as "pool," which can mean either a body of water or the action of combining the contents of two or more tubes.

"As a community, we've standardized the way the data itself is represented," said Butte, "but there are no formal requirements for the accompanying textual descriptions of this data. Sometimes people seem to almost copy and paste their entire scientific paper into the text box. We need to clean up our annotations because now we're showing that they have value."

Butte and Kohane favor using the existing Unified Medical Language System, which consists of more than 1 million biomedical concepts, to vastly simplify the computerized sorting of the thousands of microarray exper
'"/>

Source:Stanford University Medical Center


Page: 1 2 3

Related biology news :

1. Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows
2. American scientists research of lifes first cells
3. Good times ahead for dinosaur hunters, according to U of Penn scientists dinosaur census
4. New lab technique identifies high levels of pathogens in therapy pool
5. Brain-mapping technique aids understanding of sleep, wakefulness
6. Study reveals new technique for fingerprinting environmental samples
7. Researchers pioneer new gene therapy technique using natural repair process
8. Newer imaging techniques may lead to over-treatment
9. Gene silencing technique offers new strategy for treating, curing disease
10. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
11. Researchers devise new technique for creating human stem cells
Post Your Comments:
(Date:7/7/2015)... OXFORD, Conn. , July 7, 2015 NXT-ID, Inc. ... company focused on the growing mobile commerce market announces a revised ... airing this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the ...
(Date:6/30/2015)... -- Genisphere announced Tom Bliss ... develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss comes ... of the last 25 years in leadership positions at ... & Johnson. Tom started his career in Investment Banking, ... He graduated from Dartmouth College with a BA in ...
(Date:6/25/2015)... 25, 2015  TAKE Solutions Ltd., a global business ... United States Patent and Trademark Office (USPTO) for its ... TAKE Solutions, Clinical Accelerators to reduce the time taken ... to standardization without the accelerators), thus reducing time to ... At the heart of the patented Clinical Data ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3TAKE Solutions Awarded Patent By USPTO 2
... the fields of social, biological and medical science will ... discuss how they can cooperate to improve our understanding ... how our genetic inheritance is expressed (epigenetics). This collaboration ... changes have for such key social policy issues as ...
... pharmaceutical companies and four research institutions, working with the ... partnership that aims to speed the discovery of essential ... known as the TB Drug Accelerator (TBDA), will target ... early-stage research. The long-term goal of the TBDA is ...
... is home to a teeming ecosystem of microbes that is ... while the gut microbiota is interacting with our body, they ... study published online in Genome Research , ... set of viruses associated with gut microbiota in global populations. ...
Cached Biology News:World experts meet in Edinburgh to consider how life experiences impact on our genes 27 pharmaceutical companies join academic researchers to speed TB drug discovery 2Gut microbes battle a common set of viruses shared by global populations 2
(Date:7/26/2015)... ... July 26, 2015 , ... Maine Standards Company, ... / linearity test kit. The VALIDATE® ANEMIA kit contains Ferritin, Folate, and Vitamin ... using the CLSI recommended “equal delta” method for linearity testing and is liquid, ...
(Date:7/24/2015)... Pa. , July 24, 2015 Ryan ... been filed in United States District Court for the Northern ... all persons or entities that purchased the common stock of ... ) between July 31, 2014 and June 15, 2015, inclusive ... than September 8, 2015, move the Court for appointment as ...
(Date:7/24/2015)... July 24, 2015 Equity Research ... BioPharma Inc. (NASDAQ: PDLI ), Arena Pharmaceuticals Inc. ... ), Northwest Biotherapeutics Inc. (NASDAQ: NWBO ), and ... report on PDL BioPharma can be accessed at ... Composite ended at 5,146.41, down 0.49%, the Dow Jones ...
(Date:7/24/2015)... Orexigen Therapeutics, Inc. (Nasdaq: OREX ) ... quarter 2015 on Thursday, August 6 before the market ... update and discuss the financial results in a live ... (5:00 a.m. Pacific Time). The live call ... (domestic) or (847) 413-3238 (international), participant code 40327229. The ...
Breaking Biology Technology:Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5
... ( http://www.amdl.com ),AMDL, Inc. (Amex: ADL ), ... China and the US, today announced that the,Company will ... New,York City on Tuesday, October 7, 2008 at 10:30 ... Hyatt New York Hotel in the Morosco Room., ...
... Proceeds to Support R&D Efforts and Clinical ... BETHESDA, Md., Oct. 3 Micromet, Inc. ... company developing,novel, proprietary antibodies for the treatment ... that it has closed its previously,announced $40 ...
... of Aberdeen and Rothamsted Research for releasing natural insect repellents that ... technology is set to revolutionise how people protect buildings from unwanted ... ... (PRWEB) October 3, 2008 -- Atrium Innovation Ltd has developed a ...
Cached Biology Technology:AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 2AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 3Micromet Closes $40 Million Private Equity Placement 2Micromet Closes $40 Million Private Equity Placement 3Micromet Closes $40 Million Private Equity Placement 4New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS 2New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS 3New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS 4
...
... Clone/PAD: 3B8A10. ... to the C-terminal region ... Specificity: Specific for the ... Reactivity: Human (positive control: ...
Negative Control, eluted and packaged aseptically in 20l of 10mM Tris-HCL, pH 8.0, 1 mM EDTA, 5 years at either 4°C or -20°C...
...
Biology Products: